Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127003) titled 'ILR to Prevent BRCL_MCC 23608' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: Single (Participant).
Primary Sponsor: University of South Florida
Condition:
Breast Cancer Lymphedema
Intervention:
Procedure: Immediate Lymphatic Reconstruction
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2025
Target Sample Size: 98
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07127003
Published by HT Digital Content Serv...